2m 2m 2m 2m 2m 2m 2m
ALAUNOS (TCRT)
NASDAQ
$2.16+$0.01 (+0.47%)
Price as of Jun 23, 2026 7:37 PM EDT- $5.3MMarket Cap
- -51.79%1-Year Change
- BiotechnologyIndustry
ALAUNOS (TCRT)
$2.16+$0.01 (+0.47%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 5,000 -50.00% | 10,000 +100.00% | 5,000 -99.83% | 2.9M +634.17% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 5,000 -50.00% | 10,000 +100.00% | 5,000 -99.83% | 2.9M +634.17% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -1.4M +276.52% | -362,000 -97.78% | -16.3M -34.93% | -25.0M -49.60% | |
Depreciation and Amortization Expense | 7,000 +250.00% | 2,000 -99.91% | 2.3M -16.09% | 2.8M +6.24% | |
Total Operating Expenses | 4.2M -12.28% | 4.8M -85.93% | 34.3M -9.87% | 38.0M -51.21% | |
Operating Profit | -4.2M -12.20% | -4.8M -85.96% | -34.3M -2.39% | -35.1M -54.73% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | -1.9M -1.09% | -1.9M -39.09% | -3.2M +162.83% | |
Interest Income and Expense and Net | 0 +100.00% | -1.9M -1.09% | -1.9M -39.09% | -3.2M +162.83% | |
Total Nonoperating Income and Expense | 49,000 -63.16% | 133,000 +115.23% | -873,000 -66.74% | -2.6M +118.39% | |
Income before Taxes | -4.2M -12.20% | -4.8M -85.96% | -34.3M -2.39% | -35.1M -55.42% | |
Income Taxes | 0 N/A | N/A N/A | N/A N/A | N/A N/A | |
Extraordinary Items | N/A N/A | 0 -100.00% | 4.8M N/A | 0 -100.00% | |
Net Income | -4.2M -10.75% | -4.7M -86.68% | -35.1M -6.86% | -37.7M -52.09% | |
Net Income from Continuing Operations Applicable to Common | -4.2M -10.75% | -4.7M -86.68% | -35.1M -6.86% | -37.7M -52.09% | |
Basic EPS and Net Income | -2.20 -24.66% | -2.92 +32.73% | -2.20 +1,194.12% | -0.17 -54.05% | |
Diluted EPS and Net Income | -2.20 -24.66% | -2.92 +32.73% | -2.20 +1,194.12% | -0.17 -54.05% | |
Basic Weighted Average Shares | 1.9M +21.68% | 1.6M -89.99% | 16.0M -92.63% | 217.1M +1.27% | |
Diluted Weighted Average Shares | 1.9M +21.68% | 1.6M -89.99% | 16.0M -92.63% | 217.1M +1.27% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 1.4M +26.95% | 1.1M -82.00% | 6.1M -84.48% | 39.1M -48.64% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 1.4M +26.95% | 1.1M -82.00% | 6.1M -84.48% | 39.1M -48.64% | |
Total Current Assets | 2.0M -27.84% | 2.8M -66.65% | 8.3M -84.64% | 53.8M -31.75% | |
Accumulated Depreciation | 7,000 -53.33% | 15,000 +15.38% | 13,000 -99.87% | 9.8M +32.29% | |
Property and Plant and Equipment and Net | 91,000 N/A | 0 -100.00% | 2,000 -99.98% | 8.5M -22.68% | |
Total Long-Term Assets | 91,000 N/A | 0 N/A | 0 -100.00% | 500,000 -20.76% | |
Total Assets | 3.0M +7.66% | 2.8M -66.66% | 8.3M -87.28% | 64.9M -31.55% | |
Income Taxes Payable | 54,000 N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | 0 -100.00% | 16.8M +113.08% | |
Total Current Liabilities | 813,000 +17.49% | 692,000 -64.62% | 2.0M -91.91% | 24.2M +50.65% | |
Total Long-Term Debt | N/A N/A | 0 N/A | 0 N/A | 0 -100.00% | |
Total Long-Term Liabilities | N/A N/A | 0 N/A | 0 -100.00% | 28,000 -99.83% | |
Total Liabilities | 813,000 +17.49% | 692,000 -64.62% | 2.0M -92.59% | 26.4M -28.33% | |
Retained Earnings | -924.6M +0.45% | -920.4M +0.51% | -915.8M +3.99% | -880.6M +4.48% | |
Total Stockholders Equity | 2.2M +4.36% | 2.1M -67.29% | 6.3M -83.64% | 38.6M -33.59% | |
Total Shares Outstanding | 2.3M +46.73% | 1.6M -90.00% | 16.0M -93.34% | 240.4M +11.24% | |
Cash Flow | |||||
Cash from Operating Activities | -2.9M -42.29% | -5.0M -83.51% | -30.1M +3.11% | -29.2M -52.44% | |
Capital Expenditures | 98,000 N/A | 0 -100.00% | 197,000 -8.80% | 216,000 -93.50% | |
Cash from Investing Activities | -98,000 N/A | 0 -100.00% | 1.3M +797.41% | -193,000 -94.19% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 3.3M N/A | 0 +100.00% | -18.1M -384.88% | 6.4M -75.30% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -84,500.00% +75.60% | -48,120.00% -92.98% | -685,340.00% +56,944.97% | -1,201.40% -93.83% | |
Return on Assets | -145.99% +71.89% | -84.93% -11.54% | -96.01% +103.32% | -47.22% -27.68% | |
Return on Equity | -198.10% +77.19% | -111.80% -28.63% | -156.66% +100.57% | -78.11% -9.73% | |
Revenue Growth | -50.00% -150.00% | 100.00% +200.17% | -99.83% -115.74% | 634.17% +267.42% | |
Current Ratio | 2.45 -38.58% | 3.98 -5.73% | 4.22 +89.71% | 2.23 -54.70% | |
Cash Ratio | 1.70 +8.06% | 1.58 -49.13% | 3.10 +91.76% | 1.62 -65.91% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | 0.00 -100.00% | 0.43 +4.67% | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | 0.00 -100.00% | 0.26 +1.57% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow